Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2009-06-30
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Lidocaine Volume on Discomfort During Administration of Local Anesthetic
NCT02086292
Lidocaine Infusions for Chronic Pain in Children
NCT02983682
Comparison of Two Lidocaine Administration Techniques
NCT01330134
The Effect of Intravenous Lidocaine on Allodynia
NCT00659633
Effect of IV Lidocaine Infusions on Pain
NCT00725504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Adults \> 18 yrs with chronic central or peripheral neuropathic pain at the St Joseph's Health Care Pain Clinic between June and December 2009.
Outcome measures: All side effects spontaneously reported. Sedation, nausea, dizziness by Visual Analog Score Q 15 minutes; hemodynamic data q 5 minutes during and after infusion for 30 minutes.
Daily diary of side effects and Visual Analogue score of Pain for 7 days post-infusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine
Adults \>18 yrs , attending St Joseph's Health Care Pain Clinic with a diagnosis of chronic neuropathic pain who are being treated with an lidocaine infusion of 5 mg/kg over 45 minutes
Consecutive patients from two time periods:
1. June 15 to August 21, 2009
2. October 15-Dec 22,2009
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unable to speak and understand English
* Liver, kidney, or cardiac failure
* Allergy to Lidocaine
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Western Ontario, Canada
OTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
St Joseph's Health Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia K Morley-Forster, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
Associate Professor,Dept of Anesthesia and Perioperative Medicine,University of Western Ontario, Lawson Health Research Institute
Patricia K Morley-Forster, MD, FRCPC
Role: PRINCIPAL_INVESTIGATOR
Associate Professor, University of Western Ontario, Lawson Health Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Joseph's Health Care
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Attal N, Gaude V, Brasseur L, Dupuy M, Guirimand F, Parker F, Bouhassira D. Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology. 2000 Feb 8;54(3):564-74. doi: 10.1212/wnl.54.3.564.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15240E
Identifier Type: OTHER
Identifier Source: secondary_id
R-08-341
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.